• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同类型糖尿病中肠道微生物群和代谢物的独特特征:一项基于人群的横断面研究。

Distinct signatures of gut microbiota and metabolites in different types of diabetes: a population-based cross-sectional study.

作者信息

Hu Jingyi, Ding Jin, Li Xia, Li Jun, Zheng Tingting, Xie Lingxiang, Li Chenyu, Tang Yingxin, Guo Keyu, Huang Juan, Liu Shanshan, Yan Jianru, Peng Weijun, Hou Can, Wen Li, Xu Aimin, Zhou Zhiguang, Xiao Yang

机构信息

National Clinical Research Centre for Metabolic Diseases, Key Laboratory of Diabetes Immunology, Ministry of Education, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, China.

Department of Infectious Diseases and Public Health, Jockey Club College of Veterinary Medicine and Life Sciences, City University of Hong Kong, Hong Kong, China.

出版信息

EClinicalMedicine. 2023 Aug 3;62:102132. doi: 10.1016/j.eclinm.2023.102132. eCollection 2023 Aug.

DOI:10.1016/j.eclinm.2023.102132
PMID:37593224
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10430172/
Abstract

BACKGROUND

Patients with type 1 diabetes (T1D) and type 2 diabetes (T2D) present intestinal disturbances. Recent epidemiological data have showed that, worldwide, over half of newly diagnosed T1D patients were adults. However, the gut microbial alterations in adult-onset T1D are unclear. We aimed to identify the signatures of gut microbiota and metabolites in patients with adult-onset T1D systematically, comparing with T2D patients and healthy controls (HCs).

METHODS

This study enrolled 218 subjects from February 2019 to April 2022 (discovery cohort: 36 HCs, 51 patients with adult-onset T1D and 56 patients with T2D; validation cohort: 28 HCs, 27 patients with adult-onset T1D and 20 patients with T2D). Gut microbial profiles of the study subjects were investigated by metagenomic sequencing, and their faecal and serum metabolites were measured with targeted metabolomics. The study was registered on ClinicalTrials.gov (NCT05252728).

FINDINGS

Patients with adult-onset T1D had significant differences in the composition of bacteria and their metabolites, characterized by notable depletion of short-chain fatty acid-producing bacteria, especially . This was associated with a severe loss of phenolic acids and their derivatives, including gallic acid (associated with glucose metabolism) and 3,4-dihydroxyhydrocinnamic acid (linked with glucose metabolism and pancreatic beta cell autoimmunity). A predictive model based on six bacteria and six metabolites simultaneously discriminated adult-onset T1D from T2D and HCs with high accuracy. Interestingly, bacterial-viral or bacterial-fungal trans-kingdom relationships, especially positive correlations between bacteriophages and beneficial bacteria, were significantly reduced in adult-onset T1D compared to HCs.

INTERPRETATION

Adult-onset T1D patients exhibit unique changes in host-microbiota-metabolite interactions. Gut microbiota and metabolite-based algorithms could be used as additional tools for differential diagnosis of different types of diabetes and beyond.

FUNDING

National Key Research and Development Program of China, the National Natural Science Foundation of China.

摘要

背景

1型糖尿病(T1D)和2型糖尿病(T2D)患者存在肠道功能紊乱。最近的流行病学数据显示,在全球范围内,新诊断的T1D患者中有超过一半是成年人。然而,成人发病型T1D患者的肠道微生物改变尚不清楚。我们旨在系统地识别成人发病型T1D患者肠道微生物群和代谢物的特征,并与T2D患者和健康对照(HCs)进行比较。

方法

本研究于2019年2月至2022年4月招募了218名受试者(发现队列:36名HCs、51名成人发病型T1D患者和56名T2D患者;验证队列:28名HCs、27名成人发病型T1D患者和20名T2D患者)。通过宏基因组测序研究受试者的肠道微生物谱,并用靶向代谢组学方法测量其粪便和血清代谢物。该研究已在ClinicalTrials.gov上注册(NCT05252728)。

研究结果

成人发病型T1D患者在细菌组成及其代谢物方面存在显著差异,其特征是产生短链脂肪酸的细菌显著减少,尤其是 。这与酚酸及其衍生物的严重损失有关,包括没食子酸(与葡萄糖代谢有关)和3,4-二羟基肉桂酸(与葡萄糖代谢和胰腺β细胞自身免疫有关)。基于六种细菌和六种代谢物的预测模型能够以高精度同时区分成人发病型T1D与T2D和HCs。有趣的是,与HCs相比,成人发病型T1D患者中细菌-病毒或细菌-真菌跨界关系,尤其是噬菌体与有益细菌之间的正相关关系显著减少。

解读

成人发病型T1D患者在宿主-微生物群-代谢物相互作用方面表现出独特变化。基于肠道微生物群和代谢物的算法可作为鉴别不同类型糖尿病及其他疾病的辅助工具。

资金来源

中国国家重点研发计划、中国国家自然科学基金。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f922/10430172/e61399eb2e51/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f922/10430172/c99a426cc855/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f922/10430172/0536d56975b2/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f922/10430172/db61929a0684/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f922/10430172/69c2061d6cc1/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f922/10430172/c4ace6c1f388/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f922/10430172/f0fa6620cd19/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f922/10430172/e61399eb2e51/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f922/10430172/c99a426cc855/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f922/10430172/0536d56975b2/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f922/10430172/db61929a0684/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f922/10430172/69c2061d6cc1/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f922/10430172/c4ace6c1f388/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f922/10430172/f0fa6620cd19/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f922/10430172/e61399eb2e51/gr7.jpg

相似文献

1
Distinct signatures of gut microbiota and metabolites in different types of diabetes: a population-based cross-sectional study.不同类型糖尿病中肠道微生物群和代谢物的独特特征:一项基于人群的横断面研究。
EClinicalMedicine. 2023 Aug 3;62:102132. doi: 10.1016/j.eclinm.2023.102132. eCollection 2023 Aug.
2
Gut Microbiota Profile in Patients with Type 1 Diabetes Based on 16S rRNA Gene Sequencing: A Systematic Review.基于 16S rRNA 基因测序的 1 型糖尿病患者肠道微生物群特征:系统评价。
Dis Markers. 2020 Aug 27;2020:3936247. doi: 10.1155/2020/3936247. eCollection 2020.
3
Comprehensive relationships between gut microbiome and faecal metabolome in individuals with type 2 diabetes and its complications.2 型糖尿病及其并发症患者肠道微生物组与粪便代谢组的综合关系。
Endocrine. 2019 Dec;66(3):526-537. doi: 10.1007/s12020-019-02103-8. Epub 2019 Oct 7.
4
Gut microbial metabolic signatures in diabetes mellitus and potential preventive and therapeutic applications.肠道微生物代谢特征与糖尿病及其潜在的预防和治疗应用。
Gut Microbes. 2024 Jan-Dec;16(1):2401654. doi: 10.1080/19490976.2024.2401654. Epub 2024 Oct 18.
5
Machine learning approach reveals microbiome, metabolome, and lipidome profiles in type 1 diabetes.机器学习方法揭示 1 型糖尿病中的微生物组、代谢组和脂质组特征。
J Adv Res. 2024 Oct;64:213-221. doi: 10.1016/j.jare.2023.11.025. Epub 2023 Nov 30.
6
The Role of Gut Microbiota and Environmental Factors in Type 1 Diabetes Pathogenesis.肠道微生物群和环境因素在 1 型糖尿病发病机制中的作用。
Front Endocrinol (Lausanne). 2020 Feb 26;11:78. doi: 10.3389/fendo.2020.00078. eCollection 2020.
7
Microbial and metabolomic profiles of type 1 diabetes with depression: A case-control study.1 型糖尿病伴抑郁的微生物和代谢组学特征:病例对照研究。
J Diabetes. 2024 Apr;16(4):e13542. doi: 10.1111/1753-0407.13542.
8
Exploring the gut microbiota in patients with pre-diabetes and treatment naïve diabetes type 2 - a pilot study.探讨空腹血糖受损和未经治疗的 2 型糖尿病患者的肠道微生物群 - 一项初步研究。
BMC Endocr Disord. 2023 Aug 21;23(1):179. doi: 10.1186/s12902-023-01432-0.
9
Trans-ethnic gut microbiota signatures of type 2 diabetes in Denmark and India.丹麦和印度的跨种族 2 型糖尿病肠道微生物群特征。
Genome Med. 2021 Mar 3;13(1):37. doi: 10.1186/s13073-021-00856-4.
10
Association between intestinal permeability and faecal microbiota composition in Italian children with beta cell autoimmunity at risk for type 1 diabetes.1型糖尿病风险的意大利β细胞自身免疫性儿童肠道通透性与粪便微生物群组成之间的关联。
Diabetes Metab Res Rev. 2016 Oct;32(7):700-709. doi: 10.1002/dmrr.2790. Epub 2016 Mar 30.

引用本文的文献

1
Gut Microbiota and Metabolites: Biomarkers and Therapeutic Targets for Diabetes Mellitus and Its Complications.肠道微生物群与代谢产物:糖尿病及其并发症的生物标志物和治疗靶点
Nutrients. 2025 Aug 11;17(16):2603. doi: 10.3390/nu17162603.
2
Investigating Multi-Omic Signatures of Ethnicity and Dysglycaemia in Asian Chinese and European Caucasian Adults: Cross-Sectional Analysis of the TOFI_Asia Study at 4-Year Follow-Up.亚洲华裔和欧洲白种成年人中种族与血糖异常的多组学特征研究:TOFI_Asia研究4年随访的横断面分析
Metabolites. 2025 Aug 1;15(8):522. doi: 10.3390/metabo15080522.
3
From gut to joint: the protective impact of on rheumatoid arthritis.

本文引用的文献

1
Functional and metabolic alterations of gut microbiota in children with new-onset type 1 diabetes.新发 1 型糖尿病患儿肠道菌群的功能和代谢改变。
Nat Commun. 2022 Oct 26;13(1):6356. doi: 10.1038/s41467-022-33656-4.
2
The Incidence of Adult-Onset Type 1 Diabetes: A Systematic Review From 32 Countries and Regions.成人发病型 1 型糖尿病的发病率:来自 32 个国家和地区的系统评价。
Diabetes Care. 2022 Apr 1;45(4):994-1006. doi: 10.2337/dc21-1752.
3
The Gut Microbiome of Adults With Type 1 Diabetes and Its Association With the Host Glycemic Control.
从肠道到关节:[具体内容]对类风湿关节炎的保护作用
Front Immunol. 2025 Jul 25;16:1607804. doi: 10.3389/fimmu.2025.1607804. eCollection 2025.
4
A type 1 diabetes genetic risk score discriminates between type 1 diabetes and type 2 diabetes in a Chinese population.1型糖尿病遗传风险评分可区分中国人群中的1型糖尿病和2型糖尿病。
Diabetologia. 2025 Jun 26. doi: 10.1007/s00125-025-06455-x.
5
Isomeric Fatty Acids in Children and Young Adults with Type 1 Diabetes Mellitus.1型糖尿病儿童和青少年中的异构脂肪酸
Nutrients. 2025 Jun 1;17(11):1907. doi: 10.3390/nu17111907.
6
Restoration of intestinal secondary bile acid synthesis: A potential approach to improve pancreatic β cell function in type 1 diabetes.恢复肠道次级胆汁酸合成:改善1型糖尿病患者胰腺β细胞功能的一种潜在方法。
Cell Rep Med. 2025 May 20;6(5):102130. doi: 10.1016/j.xcrm.2025.102130. Epub 2025 May 9.
7
Paeoniflorin: a review of its pharmacology, pharmacokinetics and toxicity in diabetes.芍药苷:糖尿病药理学、药代动力学及毒性研究综述
Front Pharmacol. 2025 Apr 7;16:1551368. doi: 10.3389/fphar.2025.1551368. eCollection 2025.
8
Predicting diabetic kidney disease with serum metabolomics and gut microbiota.利用血清代谢组学和肠道微生物群预测糖尿病肾病
Sci Rep. 2025 Apr 9;15(1):12179. doi: 10.1038/s41598-025-91281-9.
9
Protective Role of Dietary Polyphenols in the Management and Treatment of Type 2 Diabetes Mellitus.膳食多酚在2型糖尿病管理和治疗中的保护作用
Nutrients. 2025 Jan 13;17(2):275. doi: 10.3390/nu17020275.
10
A legume-enriched diet improves metabolic health in prediabetes mediated through gut microbiome: a randomized controlled trial.富含豆类的饮食通过肠道微生物群介导改善糖尿病前期的代谢健康:一项随机对照试验。
Nat Commun. 2025 Jan 22;16(1):942. doi: 10.1038/s41467-025-56084-6.
1 型糖尿病成人的肠道微生物组及其与宿主血糖控制的关系。
Diabetes Care. 2022 Mar 1;45(3):555-563. doi: 10.2337/dc21-1656.
4
Whole gut virome analysis of 476 Japanese revealed a link between phage and autoimmune disease.对 476 名日本人的全肠道病毒组分析显示噬菌体与自身免疫性疾病之间存在关联。
Ann Rheum Dis. 2022 Feb;81(2):278-288. doi: 10.1136/annrheumdis-2021-221267. Epub 2021 Dec 8.
5
Adult-Onset Type 1 Diabetes: Current Understanding and Challenges.成人起病型 1 型糖尿病:当前认识与挑战。
Diabetes Care. 2021 Nov;44(11):2449-2456. doi: 10.2337/dc21-0770.
6
Characteristics of the Gut Microbiota and Metabolism in Patients With Latent Autoimmune Diabetes in Adults: A Case-Control Study.成人潜伏自身免疫性糖尿病患者的肠道微生物群特征和代谢:一项病例对照研究。
Diabetes Care. 2021 Dec;44(12):2738-2746. doi: 10.2337/dc20-2975. Epub 2021 Oct 7.
7
The Management of Type 1 Diabetes in Adults. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).《成人 1 型糖尿病管理:美国糖尿病协会 (ADA) 与欧洲糖尿病研究协会 (EASD) 的共识报告》
Diabetes Care. 2021 Nov;44(11):2589-2625. doi: 10.2337/dci21-0043. Epub 2021 Sep 30.
8
Viruses and Type 1 Diabetes: From Enteroviruses to the Virome.病毒与1型糖尿病:从肠道病毒到病毒组
Microorganisms. 2021 Jul 16;9(7):1519. doi: 10.3390/microorganisms9071519.
9
Alterations in the Gut Virome in Obesity and Type 2 Diabetes Mellitus.肥胖症和 2 型糖尿病中肠道病毒组的改变。
Gastroenterology. 2021 Oct;161(4):1257-1269.e13. doi: 10.1053/j.gastro.2021.06.056. Epub 2021 Jun 25.
10
Decreased Abundance of Akkermansia muciniphila Leads to the Impairment of Insulin Secretion and Glucose Homeostasis in Lean Type 2 Diabetes.瘦型 2 型糖尿病中阿克曼氏菌属黏液亚种丰度降低导致胰岛素分泌受损和葡萄糖内稳态紊乱。
Adv Sci (Weinh). 2021 Aug;8(16):e2100536. doi: 10.1002/advs.202100536. Epub 2021 Jun 4.